These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 15816157

  • 21. Trends and associations of Trichomonas vaginalis infection in men and women with genital discharge syndromes in Johannesburg, South Africa.
    Lewis DA, Marsh K, Radebe F, Maseko V, Hughes G.
    Sex Transm Infect; 2013 Sep; 89(6):523-7. PubMed ID: 23605850
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of Trichomonas vaginalis infection in and around Surat.
    Chakraborty T, Mulla SA, Kosambiya JK, Desai VK.
    Indian J Pathol Microbiol; 2005 Oct; 48(4):542-5. PubMed ID: 16366122
    [Abstract] [Full Text] [Related]

  • 23. Prevalence of Trichomonas vaginalis infection among young reproductive age women in India: implications for treatment and prevention.
    Madhivanan P, Bartman MT, Pasutti L, Krupp K, Arun A, Reingold AL, Klausner JD.
    Sex Health; 2009 Dec; 6(4):339-44. PubMed ID: 19917204
    [Abstract] [Full Text] [Related]

  • 24. A clinical study on the association of Trichomonas vaginalis and Mycoplasma hominis infections in women attending a sexually transmitted disease (STD) outpatient clinic.
    van Belkum A, van der Schee C, van der Meijden WI, Verbrugh HA, Sluiters HJ.
    FEMS Immunol Med Microbiol; 2001 Dec; 32(1):27-32. PubMed ID: 11750218
    [Abstract] [Full Text] [Related]

  • 25. [Investigation of the prevalence of Trichomonas vaginalis among female Syrian refugees with the complaints of vaginitis aged between 15-49 years].
    Yentür Doni N, Aksoy M, Şimşek Z, Gürses G, Hilali NG, Yıldız Zeyrek F, Özek B, Yıldırımkaya G.
    Mikrobiyol Bul; 2016 Oct; 50(4):590-597. PubMed ID: 28124964
    [Abstract] [Full Text] [Related]

  • 26. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
    Krashin JW, Koumans EH, Bradshaw-Sydnor AC, Braxton JR, Evan Secor W, Sawyer MK, Markowitz LE.
    Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
    [Abstract] [Full Text] [Related]

  • 27. Aptima Trichomonas vaginalis assay elucidates significant underdiagnosis of trichomoniasis among women in Brazil according to an observational study.
    Bruni MP, Freitas da Silveira M, Stauffert D, Bicca GLO, Caetano Dos Santos C, da Rosa Farias NA, Golparian D, Unemo M.
    Sex Transm Infect; 2019 Mar; 95(2):129-132. PubMed ID: 30154157
    [Abstract] [Full Text] [Related]

  • 28. Association of Trichomonas vaginalis with sociodemographic factors and other STDs among female inmates in Lisbon.
    Garcia A, Exposto F, Prieto E, Lopes M, Duarte A, Correia da Silva R.
    Int J STD AIDS; 2004 Sep; 15(9):615-8. PubMed ID: 15339370
    [Abstract] [Full Text] [Related]

  • 29. The prevalence of trichomoniasis and associated factors among women treated at a university hospital in southern Brazil.
    Gatti FA, Ceolan E, Greco FS, Santos PC, Klafke GB, de Oliveira GR, Von Groll A, de Martinez AM, Gonçalves CV, Scaini CJ.
    PLoS One; 2017 Sep; 12(3):e0173604. PubMed ID: 28346531
    [Abstract] [Full Text] [Related]

  • 30. Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations.
    Roth AM, Williams JA, Ly R, Curd K, Brooks D, Arno J, Van Der Pol B.
    Sex Transm Dis; 2011 May; 38(5):398-400. PubMed ID: 21217417
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.
    Balkus JE, Richardson BA, Mochache V, Chohan V, Chan JD, Masese L, Shafi J, Marrazzo J, Farquhar C, McClelland RS.
    Sex Transm Dis; 2013 Jun; 40(6):499-505. PubMed ID: 23677023
    [Abstract] [Full Text] [Related]

  • 33. Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics.
    Helms DJ, Mosure DJ, Metcalf CA, Douglas JM, Malotte CK, Paul SM, Peterman TA.
    Sex Transm Dis; 2008 May; 35(5):484-8. PubMed ID: 18360314
    [Abstract] [Full Text] [Related]

  • 34. Genital infections and risk of premature rupture of membranes in Mulago Hospital, Uganda: a case control study.
    Nakubulwa S, Kaye DK, Bwanga F, Tumwesigye NM, Mirembe FM.
    BMC Res Notes; 2015 Oct 16; 8():573. PubMed ID: 26475265
    [Abstract] [Full Text] [Related]

  • 35. Epidemiology of Trichomonas vaginalis and human papillomavirus infection detected by real-time PCR in flanders.
    Depuydt CE, Leuridan E, Van Damme P, Bogers J, Vereecken AJ, Donders GG.
    Gynecol Obstet Invest; 2010 Oct 16; 70(4):273-80. PubMed ID: 21051847
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Role of polymerase chain reaction in the diagnosis of Trichomonas vaginalis infection in human immunodeficiency virus-infected individuals from India (South).
    Paul H, Peter D, Pulimood SA, Abraham OC, Mathai E, Prasad JH, Kannangai R.
    Indian J Dermatol Venereol Leprol; 2012 Oct 16; 78(3):323-7. PubMed ID: 22565432
    [Abstract] [Full Text] [Related]

  • 39. A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy.
    Masese LN, Graham SM, Gitau R, Peshu N, Jaoko W, Ndinya-Achola JO, Mandaliya K, Richardson BA, Overbaugh J, McClelland RS.
    BMC Infect Dis; 2011 Nov 03; 11():307. PubMed ID: 22047086
    [Abstract] [Full Text] [Related]

  • 40. Trichomonas vaginalis and amplification of HIV-1 transmission.
    Sorvillo F, Kerndt P.
    Lancet; 1998 Jan 17; 351(9097):213-4. PubMed ID: 9449891
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.